Investigation of a Candida auris outbreak in a Skilled Nursing Facility — Virginia, United States, October 2020–June 2021

Published:December 16, 2022DOI:


      • Virginia observed an increase in the incidence of Candida auris from 2020-2021.
      • Most new cases identified in a ventilator skilled nursing facility (vSNF).
      • Two clades were identified, indicating distinct C. auris introductions.
      • Regional facilities should collaborate on infection prevention and control practices.
      • vSNFs must prioritize multidrug-resistant organism prevention strategies.


      Candida auris, an emerging multi-drug resistant organism (MDRO), is an urgent public health threat. We report on a C. auris outbreak investigation at a Virginia ventilator skilled nursing facility (vSNF). During October 2020–June 2021, we identified 28 cases among residents in the ventilator unit. Genomic evidence suggested ≥2 distinct C. auris introductions to the facility. We identified multiple infection and prevention control challenges, highlighting the importance of strengthening MDRO prevention efforts at vSNFs.


      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Infection Control
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Halili MLM
        • Sorensen GG.
        Incidence and management of Candida Auris in a skilled nursing home.
        Am J Infect Control. 2020; 48: S15-S16
        • Eckbo EJ
        • Wong T
        • Bharat A
        • et al.
        First reported outbreak of the emerging pathogen Candida auris in Canada.
        Am J Infect Control. 2021; 49: 804-807
        • Southwick KL
        • Greenko JA
        • Adams E
        • et al.
        A description of the first Candida auris-colonized individuals in New York State.
        Am J Infect Control. 2016; 47 (-2017): S10
      1. Pennsylvania Department of Health. Alert: New outbreak and containment of Candida auris in PA healthcare facilities; 2020 [cited 2021 Aug 13]. Available from:

        • Prestel C
        • Anderson E
        • Forsberg K
        • et al.
        Candida auris outbreak in a COVID-19 specialty care unit — Florida, July–August 2020.
        MMWR Morb Mortal Wkly Rep. 2021; 70: 56-57
        • Lyman M
        • Forsberg K
        • Reuben J
        • et al.
        Notes from the field: Transmission of pan-resistant and echinocandin-resistant Candida auris in health care facilities ― Texas and the District of Columbia, January–April 2021.
        MMWR Morb Mortal Wkly Rep. 2021; 70: 1022-1023
      2. Centers for Disease Control and Prevention. Tracking Candida auris; 2021 [cited 2021 Sept 21]. Available from:

        • Chow NA
        • Gade L
        • Tsay SV
        • et al.
        Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: A molecular epidemiological survey.
        Lancet Infect Dis. 2018; 18: 1377-1384
        • Centers for Disease Control and Prevention
        National Notifiable Diseases Surveillance System (NNDSS) Candida auris 2019 Case Definition.
        Reviewed. April 16, 2021;
      3. Centers for Disease Control and Prevention. Interim Guidance for a Public Health Response to Contain Novel or Targeted Multidrug-resistant Organisms (MDROs). Updated January 2019.